BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

546 related articles for article (PubMed ID: 33958804)

  • 1. Neuronal ApoE upregulates MHC-I expression to drive selective neurodegeneration in Alzheimer's disease.
    Zalocusky KA; Najm R; Taubes AL; Hao Y; Yoon SY; Koutsodendris N; Nelson MR; Rao A; Bennett DA; Bant J; Amornkul DJ; Xu Q; An A; Cisne-Thomson O; Huang Y
    Nat Neurosci; 2021 Jun; 24(6):786-798. PubMed ID: 33958804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuron-specific apolipoprotein e4 proteolysis is associated with increased tau phosphorylation in brains of transgenic mice.
    Brecht WJ; Harris FM; Chang S; Tesseur I; Yu GQ; Xu Q; Dee Fish J; Wyss-Coray T; Buttini M; Mucke L; Mahley RW; Huang Y
    J Neurosci; 2004 Mar; 24(10):2527-34. PubMed ID: 15014128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apolipoprotein E isoform-specific regulation of dendritic spine morphology in apolipoprotein E transgenic mice and Alzheimer's disease patients.
    Ji Y; Gong Y; Gan W; Beach T; Holtzman DM; Wisniewski T
    Neuroscience; 2003; 122(2):305-15. PubMed ID: 14614898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human ApoE Isoforms Differentially Modulate Brain Glucose and Ketone Body Metabolism: Implications for Alzheimer's Disease Risk Reduction and Early Intervention.
    Wu L; Zhang X; Zhao L
    J Neurosci; 2018 Jul; 38(30):6665-6681. PubMed ID: 29967007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. OCIAD1 contributes to neurodegeneration in Alzheimer's disease by inducing mitochondria dysfunction, neuronal vulnerability and synaptic damages.
    Li X; Wang L; Cykowski M; He T; Liu T; Chakranarayan J; Rivera A; Zhao H; Powell S; Xia W; Wong STC
    EBioMedicine; 2020 Jan; 51():102569. PubMed ID: 31931285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ApoE4 markedly exacerbates tau-mediated neurodegeneration in a mouse model of tauopathy.
    Shi Y; Yamada K; Liddelow SA; Smith ST; Zhao L; Luo W; Tsai RM; Spina S; Grinberg LT; Rojas JC; Gallardo G; Wang K; Roh J; Robinson G; Finn MB; Jiang H; Sullivan PM; Baufeld C; Wood MW; Sutphen C; McCue L; Xiong C; Del-Aguila JL; Morris JC; Cruchaga C; ; Fagan AM; Miller BL; Boxer AL; Seeley WW; Butovsky O; Barres BA; Paul SM; Holtzman DM
    Nature; 2017 Sep; 549(7673):523-527. PubMed ID: 28959956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Astroglial regulation of apolipoprotein E expression in neuronal cells. Implications for Alzheimer's disease.
    Harris FM; Tesseur I; Brecht WJ; Xu Q; Mullendorff K; Chang S; Wyss-Coray T; Mahley RW; Huang Y
    J Biol Chem; 2004 Jan; 279(5):3862-8. PubMed ID: 14585838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of apolipoprotein E (ApoE) genotype on biomarkers of amyloidogenesis, tau pathology and neurodegeneration in Alzheimer's disease.
    Leoni V
    Clin Chem Lab Med; 2011 Mar; 49(3):375-83. PubMed ID: 21388338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of human apolipoprotein E3 or E4 in the brains of Apoe-/- mice: isoform-specific effects on neurodegeneration.
    Buttini M; Orth M; Bellosta S; Akeefe H; Pitas RE; Wyss-Coray T; Mucke L; Mahley RW
    J Neurosci; 1999 Jun; 19(12):4867-80. PubMed ID: 10366621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amyloid-β protein modulates the perivascular clearance of neuronal apolipoprotein E in mouse models of Alzheimer's disease.
    Rolyan H; Feike AC; Upadhaya AR; Waha A; Van Dooren T; Haass C; Birkenmeier G; Pietrzik CU; Van Leuven F; Thal DR
    J Neural Transm (Vienna); 2011 May; 118(5):699-712. PubMed ID: 21210284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential Signaling Mediated by ApoE2, ApoE3, and ApoE4 in Human Neurons Parallels Alzheimer's Disease Risk.
    Huang YA; Zhou B; Nabet AM; Wernig M; Südhof TC
    J Neurosci; 2019 Sep; 39(37):7408-7427. PubMed ID: 31331998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plastic neuronal remodeling is impaired in patients with Alzheimer's disease carrying apolipoprotein epsilon 4 allele.
    Arendt T; Schindler C; Brückner MK; Eschrich K; Bigl V; Zedlick D; Marcova L
    J Neurosci; 1997 Jan; 17(2):516-29. PubMed ID: 8987775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Novel Apolipoprotein E Antagonist Functionally Blocks Apolipoprotein E Interaction With N-terminal Amyloid Precursor Protein, Reduces β-Amyloid-Associated Pathology, and Improves Cognition.
    Sawmiller D; Habib A; Hou H; Mori T; Fan A; Tian J; Zeng J; Giunta B; Sanberg PR; Mattson MP; Tan J
    Biol Psychiatry; 2019 Aug; 86(3):208-220. PubMed ID: 31208706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ApoE4 reduction: An emerging and promising therapeutic strategy for Alzheimer's disease.
    Li Y; Macyczko JR; Liu CC; Bu G
    Neurobiol Aging; 2022 Jul; 115():20-28. PubMed ID: 35453035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Astrocytes down-regulate neuronal beta-amyloid precursor protein expression and modify its processing in an apolipoprotein E isoform-specific manner.
    Vincent B; Smith JD
    Eur J Neurosci; 2001 Jul; 14(2):256-66. PubMed ID: 11553277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuronal injury-induced expression and release of apolipoprotein E in mixed neuron/glia co-cultures: nuclear factor kappaB inhibitors reduce basal and lesion-induced secretion of apolipoprotein E.
    Petegnief V; Saura J; de Gregorio-Rocasolano N; Paul SM
    Neuroscience; 2001; 104(1):223-34. PubMed ID: 11311545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regionally specific neuronal expression of human APOE gene in transgenic mice.
    Xu PT; Gilbert JR; Qiu HL; Rothrock-Christian T; Settles DL; Roses AD; Schmechel DE
    Neurosci Lett; 1998 Apr; 246(2):65-8. PubMed ID: 9627181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Humanized APOE genotypes influence lifespan independently of tau aggregation in the P301S mouse model of tauopathy.
    Williams T; Bathe T; Vo Q; Sacilotto P; McFarland K; Ruiz AJ; Hery GP; Sullivan P; Borchelt DR; Prokop S; Chakrabarty P
    Acta Neuropathol Commun; 2023 Jun; 11(1):99. PubMed ID: 37337279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reducing Endogenous α-Synuclein Mitigates the Degeneration of Selective Neuronal Populations in an Alzheimer's Disease Transgenic Mouse Model.
    Spencer B; Desplats PA; Overk CR; Valera-Martin E; Rissman RA; Wu C; Mante M; Adame A; Florio J; Rockenstein E; Masliah E
    J Neurosci; 2016 Jul; 36(30):7971-84. PubMed ID: 27466341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apolipoprotein E isoforms in Alzheimer's disease pathology and etiology.
    Baum L; Chen L; Ng HK; Pang CP
    Microsc Res Tech; 2000 Aug; 50(4):278-81. PubMed ID: 10936880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.